The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Announcements & Notices       

2024-December-4	UPDATED INFORNATION ON THE GROUP'S PRODUCT MUPIROCIN OINTMENT (in PDF)
2024-November-14	VOLUNTARY ANNOUNCEMENT VESTING OF AWARD SHARES (in PDF)
2024-November-14	THE GROUP'S PRODUCT CEFUROXIME SODIUM FOR INJECTION PASSED THE CONSISTENCY EVALUATION (in PDF)
2024-November-7	VOLUNTARY ANNOUNCEMENT ACQUISITION OF AWARD SHARES (in PDF)
2024-October-25	THE GROUP'S PRODUCT CEFTAZIDIME FOR INJECTION PASSED THE CONSISTENCY EVALUATION (in PDF)
2024-October-16	THE GROUP'S PRODUCT AMOXICILLIN GRANULES PASSED THE CONSISTENCY EVALUATION (in PDF)
2024-October-14	UPDATED INFORMATION ON THE GROUP'S PRODUCT INSULIN DEGLUDEC INJECTION (in PDF)
2024-October-14	PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT TUL12101 EYE DROPS (in PDF)
2024-September-25	SUPPLEMENTAL ANNOUNCEMENT THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 (in PDF)
2024-September-25	Interim dividend for the six months ended 30 June 2024 (in PDF)
2024-September-25	PAYMENT OF 2024 INTERIM DIVIDEND (in PDF)
2024-August-30	Interim dividend for the six months ended 30 June 2024 (in PDF)
2024-August-29	Interim Results Announcement for the six months ended 30 June 2024 (in PDF)
2024-August-15	POSITIVE PROFIT ALERT (in PDF)
2024-August-15	DATE OF BOARD MEETING (in PDF)
2024-August-12	PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT UBT251 INJECTION (in PDF)
2024-July-1	Special dividend for the year ended 31 December 2023 (in PDF)
2024-July-1	Final dividend for the year ended 31 December 2023 (in PDF)
2024-June-28	PAYMENT OF 2023 FINAL DIVIDEND AND SPECIAL DIVIDEND (in PDF)
2024-June-20	POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING (in PDF)
2024-June-11	List of Directors and Their Role and Function (in PDF)
2024-June-3	CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE MASTER SALES AGREEMENT (in PDF)
2024-May-7	Special dividend for the year ended 31 December 2023 (in PDF)
2024-May-7	Final dividend for the year ended 31 December 2023 (in PDF)
2024-May-7	CHANGE OF BOOK CLOSURE PERIOD AND RECORD DATE FOR FINAL DIVIDEND AND SPECIAL DIVIDEND (in PDF)
2024-April-29	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2024-April-24	UPDATED INFORMATION ON THE GROUP'S PRODUCT AMOXICILLIN CLAVULANATE POTASSIUM TABLETS (in PDF)
2024-April-23	VOLUNTARY ANNOUNCEMENT PROPOSED BID-WINNING RESULTS OF NATIONAL CENTRALISED PROCUREMENT OF PHARMACEUTICALS (SPECIALISING RENEWAL IN INSULIN) (in PDF)
2024-April-2	Special dividend for the year ended 31 December 2023 (in PDF)
2024-April-2	Final dividend for the year ended 31 December 2023 (in PDF)
2024-March-27	2023 ANNUAL RESULTS ANNOUNCEMENT (in PDF)
2024-March-14	POSITIVE PROFIT ALERT (in PDF)
2024-March-11	DATE OF BOARD MEETING (in PDF)
2024-January-17	UPDATED INFORMATION ON THE GROUP'S PRODUCT - IMIPENEM AND CILASTATIN SODIUM FOR INJECTION (in PDF)
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices
2016	2016 Announcements & Notices
2015	2015 Announcements & Notices
2014	2014 Announcements & Notices
2013	2013 Announcements & Notices
2012	2012 Announcements & Notices
2011	2011 Announcements & Notices
2010	2010 Announcements & Notices
2009	2009 Announcements & Notices
2008	2008 Announcements & Notices
2007	2007 Announcements & Notices